Young Lung Cancer Investigator Awarded a $200,000 Grant to Support Research in Translational Immuno-oncology
April 05, 2023 13:24 ET
|
Lung Cancer Foundation of America
Los Angeles, CA, April 05, 2023 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE Lung Cancer Foundation of America (LCFA) and the International Association for the Study of Lung...
Tracheostomy Devices Market Size to Cross USD 291.3 Mn Revenue by 2031 Due to the Rise in Demand for Homecare Services | TMR Study
April 04, 2023 17:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, April 05, 2023 (GLOBE NEWSWIRE) -- According to Transparency Market Research, the global tracheostomy devices market size was valued at USD 203.7 Mn in 2021 and...
Global Interventional Oncology Devices Market Report 2023: Players Include Boston Scientific, Medtronic, Terumo, and Philips Volcano
March 30, 2023 10:18 ET
|
Research and Markets
Dublin, March 30, 2023 (GLOBE NEWSWIRE) -- The "Interventional Oncology Devices Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides...
Ocean Biomedical (NASDAQ: OCEA) Shares Detailed Research Data on Anti-Tumor Pathway Discoveries and Their Potential for Treatment of Non-Small Cell Lung Cancer, Metastatic Melanoma, and Glioblastoma by Scientific Co-founder
March 09, 2023 08:01 ET
|
Ocean Biomedical, Inc.
Providence, RI, March 09, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA). Ocean Biomedical’s Scientific Co-founder, Dr. Jack A. Elias, MD, presented details of his previously...
Baptist Cancer Center research proves incidental lung nodule program effective in detecting cancer early
March 09, 2023 08:00 ET
|
Baptist Memorial Health Care
Memphis, TN, March 09, 2023 (GLOBE NEWSWIRE) -- Memphis-based Baptist Cancer Center published a JAMA Network Open article proving the effectiveness of incidental lung nodule, or tumor, programs in...
Immuneering Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
March 06, 2023 16:05 ET
|
Immuneering Corporation
First patient dosed in Phase 1/2a clinical trial of IMM-1-104 in advanced solid tumors with any RAS mutation Provides debut guidance for IMM-1-104 program: initial Phase 1 PK and safety data expected...
Immuneering Announces Participation in March Investor Conferences
February 28, 2023 08:00 ET
|
Immuneering Corporation
CAMBRIDGE, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company developing medicines for broad populations of cancer patients with an...
Lung Cancer Surgery Market is Expected to Reach $6.7 billion | MarketsandMarkets.
February 27, 2023 07:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, Feb. 27, 2023 (GLOBE NEWSWIRE) -- The future of lung cancer surgery is looking promising. Advances in technology and improved understanding of the disease have led to an increase in the...
Chemotherapy At Home Services Market Research Report 2022: Strategic Partnerships and Collaborations Fueling Market Growth
February 03, 2023 07:33 ET
|
Research and Markets
Dublin, Feb. 03, 2023 (GLOBE NEWSWIRE) -- The "Chemotherapy At Home Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Product (Chemotherapy...
Computer Aided Diagnostics (CADx) Market Estimated to Grow at a CAGR of 13.3% from 2022 to 2030, Contrive Datum Insights
January 24, 2023 09:49 ET
|
Contrive Datum Insights Pvt Ltd
Farmington, Jan. 24, 2023 (GLOBE NEWSWIRE) -- The global Computer Aided Diagnostics (CADx) Market size was valued at USD 5.62 Billion in 2022. It is expected to expand at a compound annual growth...